List of Tables
Table 1. Lysosomal Storage Disorders Market Trends
Table 2. Lysosomal Storage Disorders Market Drivers & Opportunity
Table 3. Lysosomal Storage Disorders Market Challenges
Table 4. Lysosomal Storage Disorders Market Restraints
Table 5. Global Lysosomal Storage Disorders Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Lysosomal Storage Disorders Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Lysosomal Storage Disorders Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Lysosomal Storage Disorders Product Type
Table 9. Key Companies Time to Begin Mass Production of Lysosomal Storage Disorders
Table 10. Global Lysosomal Storage Disorders Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysosomal Storage Disorders as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Lysosomal Storage Disorders Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Lysosomal Storage Disorders Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Lysosomal Storage Disorders Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Lysosomal Storage Disorders Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Lysosomal Storage Disorders Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Lysosomal Storage Disorders Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Lysosomal Storage Disorders Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Lysosomal Storage Disorders Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Lysosomal Storage Disorders Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Lysosomal Storage Disorders Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Lysosomal Storage Disorders Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Lysosomal Storage Disorders Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Lysosomal Storage Disorders Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Lysosomal Storage Disorders Sales Value by Region (2019-2024) & (%)
Table 27. Global Lysosomal Storage Disorders Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Lysosomal Storage Disorders Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Lysosomal Storage Disorders Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Lysosomal Storage Disorders Sales Value, (2025-2030) & (US$ Million)
Table 31. Astellas Pharma Basic Information List
Table 32. Astellas Pharma Description and Business Overview
Table 33. Astellas Pharma Lysosomal Storage Disorders Products, Services and Solutions
Table 34. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Astellas Pharma (2019-2024)
Table 35. Astellas Pharma Recent Developments
Table 36. Astrazeneca Basic Information List
Table 37. Astrazeneca Description and Business Overview
Table 38. Astrazeneca Lysosomal Storage Disorders Products, Services and Solutions
Table 39. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Astrazeneca (2019-2024)
Table 40. Astrazeneca Recent Developments
Table 41. Actelion Basic Information List
Table 42. Actelion Description and Business Overview
Table 43. Actelion Lysosomal Storage Disorders Products, Services and Solutions
Table 44. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Actelion (2019-2024)
Table 45. Actelion Recent Developments
Table 46. Eli Lilly and Company Basic Information List
Table 47. Eli Lilly and Company Description and Business Overview
Table 48. Eli Lilly and Company Lysosomal Storage Disorders Products, Services and Solutions
Table 49. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Eli Lilly and Company (2019-2024)
Table 50. Eli Lilly and Company Recent Developments
Table 51. Merck & Co Basic Information List
Table 52. Merck & Co Description and Business Overview
Table 53. Merck & Co Lysosomal Storage Disorders Products, Services and Solutions
Table 54. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Merck & Co (2019-2024)
Table 55. Merck & Co Recent Developments
Table 56. Novo Nordisk Basic Information List
Table 57. Novo Nordisk Description and Business Overview
Table 58. Novo Nordisk Lysosomal Storage Disorders Products, Services and Solutions
Table 59. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Novo Nordisk (2019-2024)
Table 60. Novo Nordisk Recent Developments
Table 61. Amicus Therapeutics Basic Information List
Table 62. Amicus Therapeutics Description and Business Overview
Table 63. Amicus Therapeutics Lysosomal Storage Disorders Products, Services and Solutions
Table 64. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Amicus Therapeutics (2019-2024)
Table 65. Amicus Therapeutics Recent Developments
Table 66. Pfizer Basic Information List
Table 67. Pfizer Description and Business Overview
Table 68. Pfizer Lysosomal Storage Disorders Products, Services and Solutions
Table 69. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Pfizer (2019-2024)
Table 70. Pfizer Recent Developments
Table 71. Sanofi Basic Information List
Table 72. Sanofi Description and Business Overview
Table 73. Sanofi Lysosomal Storage Disorders Products, Services and Solutions
Table 74. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Sanofi (2019-2024)
Table 75. Sanofi Recent Developments
Table 76. BioMarin Pharmaceutical Inc. Basic Information List
Table 77. BioMarin Pharmaceutical Inc. Description and Business Overview
Table 78. BioMarin Pharmaceutical Inc. Lysosomal Storage Disorders Products, Services and Solutions
Table 79. Revenue (US$ Million) in Lysosomal Storage Disorders Business of BioMarin Pharmaceutical Inc. (2019-2024)
Table 80. BioMarin Pharmaceutical Inc. Recent Developments
Table 81. Raptor Pharmaceuticals Basic Information List
Table 82. Raptor Pharmaceuticals Description and Business Overview
Table 83. Raptor Pharmaceuticals Lysosomal Storage Disorders Products, Services and Solutions
Table 84. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Raptor Pharmaceuticals (2019-2024)
Table 85. Raptor Pharmaceuticals Recent Developments
Table 86. Protalix Biotherapeutics Inc Basic Information List
Table 87. Protalix Biotherapeutics Inc Description and Business Overview
Table 88. Protalix Biotherapeutics Inc Lysosomal Storage Disorders Products, Services and Solutions
Table 89. Revenue (US$ Million) in Lysosomal Storage Disorders Business of Protalix Biotherapeutics Inc (2019-2024)
Table 90. Protalix Biotherapeutics Inc Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Lysosomal Storage Disorders Downstream Customers
Table 94. Lysosomal Storage Disorders Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Lysosomal Storage Disorders Product Picture
Figure 2. Global Lysosomal Storage Disorders Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Lysosomal Storage Disorders Sales Value (2019-2030) & (US$ Million)
Figure 4. Lysosomal Storage Disorders Report Years Considered
Figure 5. Global Lysosomal Storage Disorders Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Lysosomal Storage Disorders Revenue in 2023
Figure 7. Lysosomal Storage Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Enzyme Replacement Therapy Picture
Figure 9. Stem Cell Therapy Picture
Figure 10. Substrate Reduction Therapy Picture
Figure 11. Chaperone Therapy Picture
Figure 12. Others Picture
Figure 13. Global Lysosomal Storage Disorders Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Lysosomal Storage Disorders Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Clinics
Figure 17. Product Picture of Stem Cell Transplant Centre
Figure 18. Product Picture of Research Institutes
Figure 19. Product Picture of Others
Figure 20. Global Lysosomal Storage Disorders Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Lysosomal Storage Disorders Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Lysosomal Storage Disorders Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Lysosomal Storage Disorders Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Lysosomal Storage Disorders Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Lysosomal Storage Disorders Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Lysosomal Storage Disorders Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Lysosomal Storage Disorders Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Lysosomal Storage Disorders Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Lysosomal Storage Disorders Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Lysosomal Storage Disorders Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Lysosomal Storage Disorders Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Lysosomal Storage Disorders Sales Value (%), (2019-2030)
Figure 33. United States Lysosomal Storage Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Lysosomal Storage Disorders Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Lysosomal Storage Disorders Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Lysosomal Storage Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Lysosomal Storage Disorders Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Lysosomal Storage Disorders Sales Value by Application (%), 2023 VS 2030
Figure 39. China Lysosomal Storage Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Lysosomal Storage Disorders Sales Value by Type (%), 2023 VS 2030
Figure 41. China Lysosomal Storage Disorders Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Lysosomal Storage Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Lysosomal Storage Disorders Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Lysosomal Storage Disorders Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Lysosomal Storage Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Lysosomal Storage Disorders Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Lysosomal Storage Disorders Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Lysosomal Storage Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Lysosomal Storage Disorders Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Lysosomal Storage Disorders Sales Value by Application (%), 2023 VS 2030
Figure 51. India Lysosomal Storage Disorders Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Lysosomal Storage Disorders Sales Value by Type (%), 2023 VS 2030
Figure 53. India Lysosomal Storage Disorders Sales Value by Application (%), 2023 VS 2030
Figure 54. Lysosomal Storage Disorders Industrial Chain
Figure 55. Lysosomal Storage Disorders Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
